Title of article :
CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy
Author/Authors :
Shademan, Behrouz Department of Medical Biology - Faculty of Medicine - EGE University, Izmir, Turkey , Karamad, Vahidreza Department of Medical Biology - Faculty of Medicine - EGE University, Izmir, Turkey , Nourazarian, Alireza Department of Basic Medical Sciences - Khoy University of Medical Sciences, Khoy, Iran , Biray Avci, Cigir Department of Medical Biology - Faculty of Medicine - EGE University, Izmir, Turkey
Pages :
14
From page :
476
To page :
489
Abstract :
Immunotherapy has become a prominent strategy for the treatment of cancer. A method that improves the immune system’s ability to attack a tumor (Enhances antigen binding). Targeted killing of malignant cells by adoptive transfer of chimeric antigen receptor (CAR) T cells is a promising immunotherapy technique in the treatment of cancers. For this purpose, the patient’s immune cells, with genetic engineering aid, are loaded with chimeric receptors that have particular antigen binding and activate cytotoxic T lymphocytes. That increases the effectiveness of immune cells and destroying cancer cells. This review discusses the basic structure and function of CAR-T cells and how antigenic targets are identified to treat different cancers and address the disadvantages of this treatment for cancer.
Keywords :
CAR-T cell , Immunotherapy , Surface receptors , Tumor microenvironment
Journal title :
Advanced Pharmaceutical Bulletin
Serial Year :
2022
Record number :
2726616
Link To Document :
بازگشت